US 10,266,850
Application 13/842,859 · Granted Apr 23, 2019
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
Estimated expiration
March 15, 2033
6y 116d remaining
Earliest effective filing
Mar 15, 2013
+ 20 years
Mar 15, 2033
PTA +78d
Jun 1, 2033
TD cap (US 10,000,772)
Mar 15, 2033
Final
Mar 15, 2033
- Earliest effective filing
- Mar 15, 2013
- + 20 years
- Mar 15, 2033
- PTA +78d
- Jun 1, 2033
- TD cap (US 10,000,772)
- Mar 15, 2033
- Final
- Mar 15, 2033
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).
Calculation details
Base term
- Filing date
- March 15, 2013
- Earliest effective filing
- March 15, 2013
- Issue date
- April 23, 2019
- PTA
- +78 days
- Base expiry (before PTA)
- March 15, 2033
March 15, 2013 + 20 years = March 15, 2033 + 78 PTA days = June 1, 2033
- PRO61/652,086 — Provisional — not used for base term
- PRO61/716,256 — Provisional — not used for base term
- PRO61/757,640 — Provisional — not used for base term
- PRO61/765,576 — Provisional — not used for base term
Terminal disclaimers
TD caps expiration to March 15, 2033 (earliest expiring referenced patent: US 10,000,772)
US 10,000,772· Application 14/685,502Capping patent
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
- Filing date
- Apr 13, 2015
- Earliest effective filing
- Mar 15, 2013
- Issue date
- Jun 19, 2018
- PTA
- 0 days
- Calculated expiration
- Mar 15, 2033
Continuation of 13/842,859, filed Mar 15, 2013, issued as US 10,266,850
Mar 15, 2013 + 20y = Mar 15, 2033
US 10,113,167· Application 15/138,604
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
- Filing date
- Apr 26, 2016
- Earliest effective filing
- Mar 15, 2013
- Issue date
- Oct 30, 2018
- PTA
- 0 days
- Calculated expiration
- Mar 15, 2033
Continuation of 14/942,782, filed Nov 16, 2015, issued as US 10,227,611
Continuation of 13/842,859, filed Mar 15, 2013, issued as US 10,266,850
Continuation of 13/842,859, filed Mar 15, 2013, issued as US 10,266,850
Continuation of 14/685,516, filed Apr 13, 2015
Continuation of 13/842,859, filed Mar 15, 2013, issued as US 10,266,850
Continuation of 14/685,514, filed Apr 13, 2015
Continuation of 13/842,859, filed Mar 15, 2013, issued as US 10,266,850
Continuation of 14/685,513, filed Apr 13, 2015
Continuation of 13/842,859, filed Mar 15, 2013, issued as US 10,266,850
Continuation of 14/685,504, filed Apr 13, 2015, issued as US 10,301,651
Continuation of 13/842,859, filed Mar 15, 2013, issued as US 10,266,850
Continuation of 14/685,502, filed Apr 13, 2015, issued as US 10,000,772
Continuation of 13/842,859, filed Mar 15, 2013, issued as US 10,266,850
Mar 15, 2013 + 20y = Mar 15, 2033
US 10,301,651· Application 14/685,504(from application 14/685,504)
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
- Filing date
- Apr 13, 2015
- Earliest effective filing
- Mar 15, 2013
- Issue date
- May 28, 2019
- PTA
- 0 days
- Calculated expiration
- Mar 15, 2033
Continuation of 13/842,859, filed Mar 15, 2013, issued as US 10,266,850
Mar 15, 2013 + 20y = Mar 15, 2033
US 10,227,611· Application 14/942,782(from application 14/942,782)
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
- Filing date
- Nov 16, 2015
- Earliest effective filing
- Mar 15, 2013
- Issue date
- Mar 12, 2019
- PTA
- 0 days
- Calculated expiration
- Mar 15, 2033
Continuation of 13/842,859, filed Mar 15, 2013, issued as US 10,266,850
Mar 15, 2013 + 20y = Mar 15, 2033
US 10,407,697· Application 15/435,233(from application 15/435,233)
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
- Filing date
- Feb 16, 2017
- Earliest effective filing
- Mar 15, 2013
- Issue date
- Sep 10, 2019
- PTA
- 0 days
- Calculated expiration
- Mar 15, 2033
Continuation of 15/138,604, filed Apr 26, 2016, issued as US 10,113,167
Continuation of 14/942,782, filed Nov 16, 2015, issued as US 10,227,611
Continuation of 13/842,859, filed Mar 15, 2013, issued as US 10,266,850
Continuation of 13/842,859, filed Mar 15, 2013, issued as US 10,266,850
Continuation of 14/685,516, filed Apr 13, 2015
Continuation of 13/842,859, filed Mar 15, 2013, issued as US 10,266,850
Continuation of 14/685,514, filed Apr 13, 2015
Continuation of 13/842,859, filed Mar 15, 2013, issued as US 10,266,850
Continuation of 14/685,513, filed Apr 13, 2015
Continuation of 13/842,859, filed Mar 15, 2013, issued as US 10,266,850
Continuation of 14/685,504, filed Apr 13, 2015, issued as US 10,301,651
Continuation of 13/842,859, filed Mar 15, 2013, issued as US 10,266,850
Continuation of 14/685,502, filed Apr 13, 2015, issued as US 10,000,772
Continuation of 13/842,859, filed Mar 15, 2013, issued as US 10,266,850
Continuation of 14/942,782, filed Nov 16, 2015, issued as US 10,227,611
Continuation of 13/842,859, filed Mar 15, 2013, issued as US 10,266,850
Continuation of 14/685,516, filed Apr 13, 2015
Continuation of 14/685,514, filed Apr 13, 2015
Continuation of 14/685,513, filed Apr 13, 2015
Continuation of 14/685,504, filed Apr 13, 2015, issued as US 10,301,651
Continuation of 14/685,502, filed Apr 13, 2015, issued as US 10,000,772
Mar 15, 2013 + 20y = Mar 15, 2033
Notes (1)
- [TD_REFS_TRUNCATED] Found 34 TD references; resolving first 5 only
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
You have the date. Your AI can have the file.
Application 13/842,859 · US 10,266,850
PatentReply compiles the prosecution history behind US 10,266,850: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new published application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US10266850Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.